Liver Failure/Cirrhosis/Portal Hypertension

You have full text access to this OnlineOpen article

Increased caffeine consumption is associated with reduced hepatic fibrosis†

  1. Apurva A. Modi1,‡,
  2. Jordan J. Feld1,2,‡,
  3. Yoon Park1,
  4. David E. Kleiner3,
  5. James E. Everhart4,
  6. T. Jake Liang1,
  7. Jay H. Hoofnagle1,§,*

Article first published online: 9 SEP 2009

DOI: 10.1002/hep.23279

Issue

Hepatology

Hepatology

Volume 51, Issue 1, pages 201–209, January 2010

Additional Information

How to Cite

Modi, A. A., Feld, J. J., Park, Y., Kleiner, D. E., Everhart, J. E., Liang, T. J. and Hoofnagle, J. H. (2010), Increased caffeine consumption is associated with reduced hepatic fibrosis. Hepatology, 51: 201–209. doi: 10.1002/hep.23279

Author Information

  1. 1

    Liver Diseases Branch, National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, MD

  2. 2

    Toronto Western Hospital Liver Clinic, Division of Gastroenterology, University of Toronto, Toronto, Canada

  3. 3

    National Cancer Institute, NIH, Bethesda, MD

  4. 4

    Division of Digestive Diseases and Nutrition, NIDDK, NIH, Bethesda, MD

  1. ‡

    These authors contributed equally to the study.

  2. §

    fax: 301-480-7926

*Director, Liver Disease Research Branch, Division of Digestive Diseases and Nutrition, NIDDK, NIH, Building 31 Room 9A27, Bethesda, MD 20892

  1. †

    Potential conflict of interest: Nothing to report.

Publication History

  1. Issue published online: 23 DEC 2009
  2. Article first published online: 9 SEP 2009
  3. Accepted manuscript online: 9 SEP 2009 12:00AM EST
  4. Manuscript Accepted: 21 AUG 2009
  5. Manuscript Received: 24 APR 2009

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article with Supporting Information (HTML) Get PDF (230K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Jeffrey W. Molloy, Christopher J. Calcagno, Christopher D. Williams, Frances J. Jones, Dawn M. Torres, Stephen A. Harrison, Association of coffee and caffeine consumption with fatty liver disease, nonalcoholic steatohepatitis, and degree of hepatic fibrosis, Hepatology, 2012, 55, 2
    Direct Link:
  2. 2
    Lijun Zhang, Dorothea M. Kujawinski, Eugen Federherr, Torsten C. Schmidt, Maik A. Jochmann, Caffeine in Your Drink: Natural or Synthetic?, Analytical Chemistry, 2012, 84, 6, 2805

    CrossRef

  3. You have free access to this content3
    A. Birerdinc, M. Stepanova, L. Pawloski, Z. M. Younossi, Caffeine is protective in patients with non-alcoholic fatty liver disease, Alimentary Pharmacology & Therapeutics, 2012, 35, 1
    Direct Link:
  4. 4
    Hashem B. El-Serag, Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma, Gastroenterology, 2012, 142, 6, 1264

    CrossRef

  5. 5
    Shiv K. Sarin, Manoj Kumar, Natural history of HCV infection, Hepatology International, 2012,

    CrossRef

  6. 6
    Angelo H. Paredes, Dawn M. Torres, Stephen A. Harrison, Nonalcoholic Fatty Liver Disease, Clinics in Liver Disease, 2012, 16, 2, 397

    CrossRef

  7. 7
    Erin Marie McCarthy, Mary E. Rinella, The Role of Diet and Nutrient Composition in Nonalcoholic Fatty Liver Disease, Journal of the Academy of Nutrition and Dietetics, 2012, 112, 3, 401

    CrossRef

  8. 8
    Charlotte E. Costentin, Françoise Roudot-Thoraval, Elie-Serge Zafrani, Fatiha Medkour, Jean-Michel Pawlotsky, Ariane Mallat, Christophe Hézode, Association of caffeine intake and histological features of chronic hepatitis C, Journal of Hepatology, 2011, 54, 6, 1123

    CrossRef

  9. 9
    Daniel Shouval, Focus, Journal of Hepatology, 2011, 54, 6, 1085

    CrossRef

  10. 10
    Ildikó Klemmer, Shintaro Yagi, Olav A. Gressner, Oral application of 1,7-dimethylxanthine (paraxanthine) attenuates the formation of experimental cholestatic liver fibrosis, Hepatology Research, 2011, 41, 11
    Direct Link:
  11. 11
    Claudia O. Zein, Lisa M. Yerian, Prema Gogate, Rocio Lopez, John P. Kirwan, Ariel E. Feldstein, Arthur J. McCullough, Pentoxifylline improves nonalcoholic steatohepatitis: A randomized placebo-controlled trial, Hepatology, 2011, 54, 5
    Direct Link:
  12. 12
    Melissa Palmer, Gastrointestinal and Liver Disease Nutrition Desk Reference, 2011,

    CrossRef

  13. 13
    Melissa Palmer, Gastrointestinal and Liver Disease Nutrition Desk Reference, 2011,

    CrossRef

  14. 14
    Melissa Palmer, Gastrointestinal and Liver Disease Nutrition Desk Reference, 2011,

    CrossRef

  15. 15
    Bruce N. Cronstein, Caffeine, a drug for all seasons, Journal of Hepatology, 2010, 53, 1, 207

    CrossRef

  16. 16
    Scott L. Friedman, Hepatic Fibrosis,
    Direct Link:
  17. 17
    Jama M. Darling, Stanley M. Lemon, Michael W. Fried, Hepatitis C,
    Direct Link:
View Full Article with Supporting Information (HTML) Get PDF (230K)